Literature DB >> 31388262

Elevated Von Willebrand Factor Antigen Levels are an Independent Risk Factor for Venous Thromboembolism: First Report from North India.

Sweta Rajpal1, Jasmina Ahluwalia1, Narender Kumar1, Pankaj Malhotra2, Varun Uppal1.   

Abstract

Elevated levels of coagulation factor VIII have been associated with increased risk for venous thromboembolism (VTE). The role of Von Willebrand factor (VWF) in VTE is unclear. In this study, we investigated the association of raised levels of VWF and factor VIII in patients with VTE. 100 patients of VTE and 100 age and gender matched controls were tested for levels of VWF antigen, coagulation factor VIII:C, Protein C, Protein S, antithrombin, antiphospholipid antibodies and for the presence of Factor V Leiden mutation. The mean level of VWF was significantly higher amongst patients of VTE (177.3 IU/dl) when compared to controls (129.7 IU/dl) (P < 0.001). Similarly, the mean level of FVIII:C was significantly higher amongst patients of VTE (199.1 IU/dl) when compared to controls (145.2 IU/dl) (P < 0.001). On logistic regression analysis, after adjusting for FVIII:C, Protein S, factor V Leiden and trauma, the association of raised VWF with VTE remained significant (P = 0.001). Similarly higher levels of FVIII:C persisted to have an independent association with VTE (P = 0.004). Both, higher levels of VWF and FVIII:C levels, are independently associated with VTE.

Entities:  

Keywords:  Factor VIII:C; VWF antigen; Venous thromboembolism

Year:  2019        PMID: 31388262      PMCID: PMC6646437          DOI: 10.1007/s12288-019-01092-y

Source DB:  PubMed          Journal:  Indian J Hematol Blood Transfus        ISSN: 0971-4502            Impact factor:   0.900


  26 in total

1.  High plasma concentration of factor VIIIc is a major risk factor for venous thromboembolism.

Authors:  R A Kraaijenhagen; P S in't Anker; M M Koopman; P H Reitsma; M H Prins; A van den Ende; H R Büller
Journal:  Thromb Haemost       Date:  2000-01       Impact factor: 5.249

2.  Amount of H antigen expressed on circulating von Willebrand factor is modified by ABO blood group genotype and is a major determinant of plasma von Willebrand factor antigen levels.

Authors:  James O'Donnell; Frank E Boulton; Richard A Manning; Michael A Laffan
Journal:  Arterioscler Thromb Vasc Biol       Date:  2002-02-01       Impact factor: 8.311

3.  ABO blood group genotypes and the risk of venous thrombosis: effect of factor V Leiden.

Authors:  V M Morelli; M C H De Visser; H L Vos; R M Bertina; F R Rosendaal
Journal:  J Thromb Haemost       Date:  2005-01       Impact factor: 5.824

4.  High factor VIII antigen levels increase the risk of venous thrombosis but are not associated with polymorphisms in the von Willebrand factor and factor VIII gene.

Authors:  P W Kamphuisen; J C Eikenboom; F R Rosendaal; T Koster; A D Blann; H L Vos; R M Bertina
Journal:  Br J Haematol       Date:  2001-10       Impact factor: 6.998

Review 5.  The relationship between ABO histo-blood group, factor VIII and von Willebrand factor.

Authors:  J O'Donnell; M A Laffan
Journal:  Transfus Med       Date:  2001-08       Impact factor: 2.019

6.  Relationship between ABO and Secretor genotype with plasma levels of factor VIII and von Willebrand factor in thrombosis patients and control individuals.

Authors:  Michael Schleef; Erwin Strobel; Andrea Dick; Josef Frank; Wolfgang Schramm; Michael Spannagl
Journal:  Br J Haematol       Date:  2005-01       Impact factor: 6.998

7.  Influence of factor VIII/von Willebrand complex on the activated protein C-resistance phenotype and on the risk for venous thromboembolism in heterozygous carriers of the factor V Leiden mutation.

Authors:  V De Mitrio; R Marino; F A Scaraggi; L Di Bari; F Giannoccaro; M Petronelli; P Ranieri; N Tannoia; O Schiraldi
Journal:  Blood Coagul Fibrinolysis       Date:  1999-10       Impact factor: 1.276

Review 8.  Venous thrombosis: a multicausal disease.

Authors:  F R Rosendaal
Journal:  Lancet       Date:  1999-04-03       Impact factor: 79.321

9.  Thrombus precursor protein, endogenous thrombin potential, von-Willebrand factor and activated factor VII in suspected deep vein thrombosis: is there a place for new parameters?

Authors:  Robert A Bucek; Markus Reiter; Peter Quehenberger; Ansgar Weltermann; Paul A Kyrle; Erich Minar
Journal:  Br J Haematol       Date:  2003-01       Impact factor: 6.998

10.  Coagulation factors, inflammation markers, and venous thromboembolism: the longitudinal investigation of thromboembolism etiology (LITE).

Authors:  Albert W Tsai; Mary Cushman; Wayne D Rosamond; Susan R Heckbert; Russell P Tracy; Nena Aleksic; Aaron R Folsom
Journal:  Am J Med       Date:  2002-12-01       Impact factor: 4.965

View more
  1 in total

1.  Plasma levels of von Willebrand factor and future risk of incident venous thromboembolism.

Authors:  Magnus S Edvardsen; Kristian Hindberg; Ellen-Sofie Hansen; Vânia M Morelli; Thor Ueland; Pål Aukrust; Sigrid K Brækkan; Line H Evensen; John-Bjarne Hansen
Journal:  Blood Adv       Date:  2021-01-12
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.